Chris Carey

Q: What is Chris Carey's success rate?

Chris Carey currently has a success rate of 93.96448573622486.

Q: What is the average return of Chris Carey's calls?

Their stock ratings have generated an average return of 6.687671339031855.

Wells Fargo | Consumer Defensive

Chris Carey is an analyst from Wells Fargo specializing in the Consumer Defensive sector. Ranked #1653 out of 4656 analysts, they have issued 127 stock ratings with a success rate of 93.96% and an average return of 6.69%.

Chris Carey has a well-established track record, with 127 ratings issued in the Consumer Defensive sector. They have consistently delivered a success rate of 93.96% and an average return of 6.69%, underscoring their expertise and ability to identify winning opportunities for investors.

#1653

Out of 4656

127

Total Ratings

+93.96%

Success Rate

+6.69%

Average Return

Recent Ratings Analysis

GIS

Sell

May 18, 2026

Target

$30.00

Current

$33.45

Performance

0.00%

Chris Carey rated GIS as Underweight on May 18, 2026, setting a price target of 30. So far, the bearish outlook hasn’t materialized, with shares flat near 33.45.

CAG

Sell

May 18, 2026

Target

$13.00

Current

$13.79

Performance

0.00%

On May 18, 2026, CAG was given a Underweight rating by Chris Carey, with a target price of 13. The stock traded sideways with only a 0.00% move, leaving the Sell case unresolved.

COCO

Buy

May 18, 2026

Target

$85.00

Current

$79.23

Performance

0.00%

COCO received a Overweight rating from Chris Carey on May 18, 2026, aiming for 85. Price action was muted, as shares hovered around 79.23 despite the bullish outlook.

TAP

Hold

May 18, 2026

Target

$43.00

Current

$41.68

Performance

0.00%

On May 18, 2026, Chris Carey published a Equal-Weight outlook on TAP, with a target of 43. Sideways action left the Hold view intact, with no major move since 41.68.

PEP

Hold

May 18, 2026

Target

$160.00

Current

$149.06

Performance

0.00%

Chris Carey on May 18, 2026 assigned PEP a Equal-Weight rating, with a price target of 160. The Hold stance reflected consolidation, as shares held near 149.06.

MNST

Buy

May 18, 2026

Target

$97.00

Current

$88.54

Performance

0.00%

On May 18, 2026, Chris Carey reaffirmed MNST with a Overweight rating, targeting 97. Market indecision has kept the 97 target in a holding pattern.

KO

Buy

May 18, 2026

Target

$90.00

Current

$81.20

Performance

0.00%

KO was rated Overweight by Chris Carey on May 18, 2026, with a price objective of 90. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

CLX

Hold

May 18, 2026

Target

$95.00

Current

$92.82

Performance

0.00%

On May 18, 2026, Chris Carey initiated coverage on CLX with a Equal-Weight rating and target of 95. The stock’s lack of movement around 92.82 aligned with a cautious approach.

BUD

Buy

May 06, 2026

Target

$93.00

Current

$81.32

Performance

-0.94%

Chris Carey issued a Overweight recommendation for BUD on May 06, 2026, price target set at 93. The target of 93 remains in play, though confirmation will depend on future moves.

HSY

Hold

May 01, 2026

Target

$200.00

Current

$191.73

Performance

—

On May 01, 2026, HSY was evaluated by Chris Carey, who gave a Equal-Weight rating and target of 200. Hold sentiment was validated by subdued trading with no breakout beyond 191.73.

PG

Buy

Apr 27, 2026

Target

$164.00

Current

$142.35

Performance

-4.08%

Chris Carey rated PG as Overweight on Apr 27, 2026, setting a price target of 164. Shares have remained stable near 142.35, leaving the 164 target still in play.

STZ

Buy

Apr 10, 2026

Target

$185.00

Current

$147.58

Performance

-11.18%

On Apr 10, 2026, STZ was given a Overweight rating by Chris Carey, with a target price of 185. Despite the Buy call, shares fell from 147.58 to 147.58, challenging the optimistic stance.

SJM

Buy

Apr 08, 2026

Target

$125.00

Current

$103.64

Performance

10.50%

SJM received a Overweight rating from Chris Carey on Apr 08, 2026, aiming for 125. Momentum has favored the Buy call, with shares climbing from 103.64 to 103.64, rewarding those who trusted the recommendation.

CHD

Buy

Apr 08, 2026

Target

$105.00

Current

$96.78

Performance

2.74%

On Apr 08, 2026, Chris Carey published a Overweight outlook on CHD, with a target of 105. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 96.78.

CL

Hold

Apr 08, 2026

Target

$92.00

Current

$89.92

Performance

5.11%

Chris Carey on Apr 08, 2026 assigned CL a Equal-Weight rating, with a price target of 92. Shares outperformed expectations, climbing 5.11% despite the neutral view.

CPB

Sell

Apr 08, 2026

Target

$18.00

Current

$20.34

Performance

-1.69%

On Apr 08, 2026, Chris Carey reaffirmed CPB with a Underweight rating, targeting 18. Price action has been neutral, giving no verdict on the Sell call.

KDP

Buy

Apr 08, 2026

Target

$37.00

Current

$29.43

Performance

13.89%

KDP was rated Overweight by Chris Carey on Apr 08, 2026, with a price objective of 37. A bullish response from the market helped close the gap of 7.57 to the target.

KMB

Hold

Apr 08, 2026

Target

$100.00

Current

$96.54

Performance

-0.47%

On Apr 08, 2026, Chris Carey initiated coverage on KMB with a Equal-Weight rating and target of 100. The stock’s lack of movement around 96.54 aligned with a cautious approach.

SMG

Buy

Apr 08, 2026

Target

$72.00

Current

$57.53

Performance

-9.86%

Chris Carey issued a Overweight recommendation for SMG on Apr 08, 2026, price target set at 72. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

KHC

Hold

Mar 12, 2026

Target

$25.00

Current

$23.35

Performance

4.57%

On Mar 12, 2026, KHC was evaluated by Chris Carey, who gave a Equal-Weight rating and target of 25. Hold sentiment was validated by subdued trading with no breakout beyond 23.35.

MDLZ

Buy

Feb 12, 2026

Target

$70.00

Current

$61.64

Performance

-0.36%

Chris Carey rated MDLZ as Overweight on Feb 12, 2026, setting a price target of 70. Shares have remained stable near 61.64, leaving the 70 target still in play.

EPC

Buy

Feb 10, 2026

Target

$22.00

Current

$16.14

Performance

-21.27%

On Feb 10, 2026, EPC was given a Overweight rating by Chris Carey, with a target price of 22. Despite the Buy call, shares fell from 16.14 to 16.14, challenging the optimistic stance.

SPB

Hold

Feb 06, 2026

Target

$80.00

Current

$77.09

Performance

1.81%

SPB received a Equal-Weight rating from Chris Carey on Feb 06, 2026, aiming for 80. Shares remained flat at 77.09, aligning with the neutral rating.

COTY

Hold

Aug 22, 2025

Target

$4.00

Current

$2.01

Performance

-48.85%

On Aug 22, 2025, Chris Carey published a Equal-Weight outlook on COTY, with a target of 4. Weakness in the stock, now at 2.01, supported the conservative rating.

NWL

Hold

Jul 09, 2025

Target

$6.00

Current

$3.65

Performance

-37.71%

Chris Carey on Jul 09, 2025 assigned NWL a Equal-Weight rating, with a price target of 6. The call successfully avoided chasing as shares lost 37.71%.

K

Hold

Aug 15, 2024

Target

$83.50

Current

$83.44

Performance

3.94%

On Aug 15, 2024, Chris Carey reaffirmed K with a Equal-Weight rating, targeting 83.5. The neutral call matched muted market action of 3.94%.

ZVIA

Hold

May 09, 2024

Target

$1.00

Current

$1.36

Performance

56.30%

ZVIA was rated Equal-Weight by Chris Carey on May 09, 2024, with a price objective of 1. Despite caution, upside momentum rewarded risk-takers with gains to 1.36.

Frequency Asked Questions

Who is Chris Carey?

Chris Carey is an analyst from Wells Fargo specializing in the Consumer Defensive sector.

What is Chris Carey's success rate?

Chris Carey currently has a success rate of +93.96%.

How many ratings has Chris Carey issued?

Chris Carey has issued 127 stock ratings so far.

What is the average return of Chris Carey's calls?

Their stock ratings have generated an average return of +6.69%.

What is Chris Carey's ranking?

Chris Carey is ranked #1653 out of 4656 analysts.

What types of ratings does Chris Carey give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Chris Carey?

You can follow Chris Carey by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Chris Carey?

Their latest rating was a Sell on GIS issued on 2026-05-18.